Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Clovis Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Clovis Oncology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Clovis Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Clovis Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Clovis Oncology Inc, Medical Devices Deals, 2012 to YTD 2018 10
Clovis Oncology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Clovis Oncology Inc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Clovis Oncology Enters into Agreement with Immunomedics 12
Bristol-Myers Squibb and Clovis Oncology Enter into Agreement 13
Clovis Oncology Enters into Agreement with Strata Oncology 14
Clovis Oncology Enters into Agreement with Genentech 15
Clovis Oncology Enters Into Co-Development Agreement With Array BioPharma 16
Licensing Agreements 17
Clovis Oncology Enters into Licensing Agreement with Gatekeeper Pharma 17
Clovis Oncology Enters into Licensing Agreement with AstraZeneca 18
Equity Offering 19
Clovis Oncology Raises USD100 Million in Public Offering of Shares 19
Clovis Oncology Raises USD342.4 Million in Public Offering of Shares 21
Clovis Oncology Raises USD235.75 million in Public Offering Of Shares 23
Clovis Oncology Raises USD316 Million in Public Offering of Shares 25
Clovis Oncology Completes Public Offering Of Shares For US$262 Million 27
Clovis Oncology Completes Public Offering Of Common Stock For US$75 Million 29
Debt Offering 31
Clovis Oncology Raises USD300 Million in Public Offering of Notes Due 2025 31
Clovis Oncology Completes Private Placement of Notes Due 2021 for USD287.5 Million 32
Acquisition 33
Clovis Oncology Acquires EOS For US$420 Million 33
Clovis Oncology Inc – Key Competitors 35
Clovis Oncology Inc – Key Employees 36
Clovis Oncology Inc – Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 38
Financial Announcements 38
Oct 30, 2018: Clovis Oncology announces third quarter 2018 operating results 38
Aug 01, 2018: Clovis Oncology announces second quarter 2018 operating results 41
May 08, 2018: Clovis Oncology Reports First Quarter 2018 Operating Results 44
Feb 26, 2018: Clovis Oncology Announces 2017 Financial Results 47
Nov 01, 2017: Clovis Oncology Announces Third Quarter 2017 Operating Results 50
Aug 02, 2017: Clovis Oncology Announces Second Quarter 2017 Operating Results 53
May 03, 2017: Clovis Oncology Announces First Quarter 2017 Operating Results 56
Feb 22, 2017: Clovis Oncology Announces 2016 Operating Results 59
Corporate Communications 61
Oct 11, 2018: Clovis Oncology appoints two new Directors to its Board 61
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62
Clovis Oncology Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Clovis Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Clovis Oncology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Clovis Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Clovis Oncology Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Clovis Oncology Inc, Medical Devices Deals, 2012 to YTD 2018 10
Clovis Oncology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Clovis Oncology Enters into Agreement with Immunomedics 12
Bristol-Myers Squibb and Clovis Oncology Enter into Agreement 13
Clovis Oncology Enters into Agreement with Strata Oncology 14
Clovis Oncology Enters into Agreement with Genentech 15
Clovis Oncology Enters Into Co-Development Agreement With Array BioPharma 16
Clovis Oncology Enters into Licensing Agreement with Gatekeeper Pharma 17
Clovis Oncology Enters into Licensing Agreement with AstraZeneca 18
Clovis Oncology Raises USD100 Million in Public Offering of Shares 19
Clovis Oncology Raises USD342.4 Million in Public Offering of Shares 21
Clovis Oncology Raises USD235.75 million in Public Offering Of Shares 23
Clovis Oncology Raises USD316 Million in Public Offering of Shares 25
Clovis Oncology Completes Public Offering Of Shares For US$262 Million 27
Clovis Oncology Completes Public Offering Of Common Stock For US$75 Million 29
Clovis Oncology Raises USD300 Million in Public Offering of Notes Due 2025 31
Clovis Oncology Completes Private Placement of Notes Due 2021 for USD287.5 Million 32
Clovis Oncology Acquires EOS For US$420 Million 33
Clovis Oncology Inc, Key Competitors 35
Clovis Oncology Inc, Key Employees 36
Clovis Oncology Inc, Other Locations 37
Clovis Oncology Inc, Subsidiaries 37
List of Figures
Clovis Oncology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Clovis Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Clovis Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Clovis Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Clovis Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Clovis Oncology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Clovis Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Clovis Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Clovis Oncology Inc, Medical Devices Deals, 2012 to YTD 2018 10